These findings suggest that obesity-related metabolic dysfunction may affect the brain even in early stages, potentially influencing cognition and behavior through mechanisms involving insulin resistance, inflammation, and disrupted central signaling. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.